Related Experiment Video
Updated: May 19, 2026
07:01
Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
Antiepileptics and bone health
Christian Meier1, Marius E Kraenzlin
1Division of Endocrinology, Diabetes and Metabolism, University Hospital, CH-4031 Basel, Switzerland.
Therapeutic Advances in Musculoskeletal Disease
|August 8, 2012
Summary
Epilepsy treatments, particularly enzyme-inducing antiepileptic drugs (AEDs), can harm bone health, reducing bone mineral density (BMD) and increasing fracture risk. Supplementation and BMD monitoring are advised for patients on long-term AED therapy.
Area of Science:
- * Endocrinology
- * Neurology
- * Metabolic Bone Disease
Background:
- * Growing evidence links epilepsy and its treatments to adverse effects on bone mineralization and calcium metabolism.
- * Enzyme-inducing antiepileptic drugs (AEDs) are associated with reduced bone mineral density (BMD) and elevated fracture risk.
- * Mechanism involves accelerated vitamin D metabolism, leading to decreased calcium absorption and secondary hyperparathyroidism.
Purpose of the Study:
- * To review the impact of antiepileptic drugs (AEDs) on bone metabolism.
- * To highlight the risks of reduced bone mineral density (BMD) and fractures in epilepsy patients.
- * To discuss current recommendations for managing bone health in patients on AEDs.
Main Methods:
- * Literature review of studies investigating epilepsy, antiepileptic drugs (AEDs), and bone health.
- * Analysis of evidence regarding the effects of enzyme-inducing and newer AEDs on bone mineral density (BMD) and calcium metabolism.
- * Synthesis of clinical recommendations for prophylaxis and monitoring.
Main Results:
- * Significant BMD reduction and increased fracture risk observed with enzyme-inducing AEDs (phenobarbital, carbamazepine, phenytoin).
- * Potential bone metabolism alterations reported for newer AEDs like oxcarbazepine, gabapentin, and levetiracetam.
- * Limited intervention studies available for specific drug therapies in epilepsy patients.
Conclusions:
- * Prophylactic calcium and vitamin D supplementation is recommended for all epilepsy patients.
- * BMD measurement is advised for long-term AED users, especially those on enzyme-inducing AEDs or with fracture risk factors.
- * Pharmacological treatment (e.g., bisphosphonates) is reserved for high-fracture-risk patients, with no epilepsy-specific interventions established.
More Related Videos
09:16Use of a Wireless Video-EEG System to Monitor Epileptiform Discharges Following Lateral Fluid-Percussion Induced Traumatic Brain Injury
Published on: June 21, 2019
09:07Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
Published on: August 15, 2017
Related Concept Videos
01:17Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
01:20Antiepileptic Drugs: Potassium Channel Activators
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
01:08Antiepileptic Drugs: Sodium Channel Blockers
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
01:14Antiepileptic Drugs: Glutamate Antagonists
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
01:24Epilepsy and Seizures: Overview
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...